Delivery Order SPE2DR25D3111-SPE2DR26FF3KY
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,951.95 for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,282.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, under a firm fixed-price contract type with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive...
- The Defense Logistics Agency awarded a delivery order valued at $2,907.40 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This is a firm fixed price delivery order with no set-aside designation, executed under a competitive award process. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,477.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen 0.5 mL, a diabetes medication, on May 12, 2025, with an ultimate completion date of May 13, 2025. The contract employs firm fixed-price pricing under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the awardee with performance occurring at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a $37,490.02 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL dosage), a diabetes medication. The contract is a firm fixed-price delivery order with no set-aside designation, issued on October 15, 2025, and scheduled for completion by October 16, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,453.70 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. Awarded on November 14, 2025, with an ultimate completion date of November 17, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,410.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The award was fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,308.24 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 25, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,153.95 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL dosage units), a diabetes management medication. This firm fixed-price, competitively awarded contract was executed on December 9, 2025, with an ultimate completion date of December 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $2,888.28 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen medication on September 26, 2025, with completion expected by September 29, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3KYDelivery Order
The Defense Logistics Agency awarded a $1,559.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a brand-name diabetes medication. The award was issued on December 2, 2025, with an ultimate completion date of December 3, 2025, and represents a non-set-aside, competitively awarded contract. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract vehicle supports DLA's pharmaceutical procurement strategy and demonstrates AmerisourceBergen's capacity as a major federal pharmaceutical distributor capable of fulfilling diverse medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/1/25 |